San Francisco CEO
January 10-11, 2026
Four Seasons, San Francisco
Longwood Healthcare Leaders San Francisco CEO brings together leading biopharma CEOs, heads of R&D, top academic researchers, and life science investors the weekend prior to the JP Morgan Healthcare Conference for off-the-record discussion, held at the Four Seasons San Francisco. Join us for an intimate event with leaders in the industry.
Featured Speakers
Highlights from last year's San Francisco CEO
Watch highlights from San Francisco CEO, including interviews with Teresa Graham (CEO, Roche Pharma), Bill Mezzanotte (Head, R&D, CSL), Levi Garraway (CMO, Roche Genentech), Jay Bradner (EVP, R&D & CSO, Amgen), Steve Hahn (former Commissioner, FDA), Marianne De Backer (CEO, Vir Bio), Jeremy Levin (CEO, Ovid Therapeutics), Mathai Mammen (CEO, Parabilis Medicines), Marc Tessier-Lavigne (CEO, Xaira), Johan Luthman (Head, R&D, Lundbeck), among others.
Venue
San Francisco CEO is hosted in downtown San Francisco immediately prior to the JP Morgan Healthcare Conference.
Four Seasons Hotel San Francisco
757 Market Street
San Francisco, CA
415-633-3000
Agenda
Saturday, January 10, 2026
7:00 am
REGISTRATION & NETWORKING BREAKFAST
7:30 am
LONGWOOD FUND INTRODUCTION
8:00 am
TRANSLATING SCIENCE INTO MEDICINE
Azad Bonni, Global Head, Pharma Research & Early Development, ad interim, Roche
Bill Dahut, CSO, American Cancer Society
Chris Loose, CEO, Progentos Therapeutics
Joanne Smith-Farrell, CEO, Be Bio
8:30 am
BIOPHARMA PIPELINE SOURCING
Tadaaki Taniguchi, Chief Research & Development Officer, Astellas
Sekhar Naik, CEO, MResult
9:00 am
THE EVOLVING DEAL-MAKING LANDSCAPE
Rachna Khosla, SVP, BD, Amgen
Stefan Köenig, CEO, Merz
Matthias Müllenbeck, SVP, Head, Global BD & Alliance Management, EMD Serono
David Redfern, President Corporate Development, GSK
9:30 am
FIRESIDE CHAT
9:50 am
NETWORKING BREAK
10:20 am
DEVELOPING AN EFFECTIVE BOARD
10:50 am
ADVANCES IN CLINICAL TRIALS
Judy Chou, CEO, AltruBio
Sandi Dunn, CEO, Phoenix Molecular Designs
11:20 am
NAVIGATING THE REGULATORY LANDSCAPE
Thomas Lonngren, former Director, EMA
11:50 am
FIRESIDE CHAT
Lloyd Minor, Dean, Stanford Medicine
12:10 pm
NETWORKING LUNCHEON
1:00 pm
R&D COLLABORATION
Leif Pedersen, President, Certara
Roby Kanichay, Head, Technologies & Externalizations, Global BD & Alliance Management, EMD Serono
1:30 pm
HEALTH EQUITY AND ENSURING ACCESS TO INNOVATION
Sabrina Johnson, CEO, Daré Bioscience
Greg Tietjen, CEO, Revalia Bio
2:00 pm
POSITIONING FOR COMMERCIAL SUCCESS
Derel Adams, CEO, Stellular Bio
Aziz Mottawala, CCO, Tarsus
Stephen Blaising, Chair, Brain Surgery Worldwide
2:30 pm
ACCELERATING DRUG DEVELOPMENT
Bruno Gomes, Head, Early Clinical Development, Oncology, Roche
Cindy Perettie, EVP, Head, Kite Pharma
Stef van Grieken, CEO, Cradle
3:00 pm
NETWORKING BREAK
3:30 pm
FIRESIDE CHAT
4:00 pm
DEVELOPING GLOBAL PARTNERSHIPS
Dan Paterson, CEO, Verastem
4:30 pm
CAPITAL MARKET OUTLOOK
5:00 – 6:30 pm
COCKTAIL RECEPTION
Sunday, January 11, 2026
7:00 am
REGISTRATION & NETWORKING BREAKFAST
7:30 am
LONGWOOD FUND INTRODUCTION
7:45 am
DRIVING PRODUCTIVITY IN R&D
Nadim Ahmed, CEO, Cullinan Therapeutics
Maureen Hillenmeyer, CEO Hexagon Bio
Aviv Regev, EVP, Research & Early Dev, Genentech
Moderator: Yiannis Kiachopoulos, CEO, Causaly
8:15 am
IMPACT OF COMPANY MINDSET & CULTURE
Will Lewis, CEO, Insmed
Trevor Martin, CEO, Mammoth Biosciences
Natalia Misciattelli, CEO, AAVantgarde Bio
Moderator: Smita Pillai, SVP, Talent Development, Inclusion & Innovation Culture, Regeneron
8:45 am
ECOSYSTEM OF EXTERNAL INNOVATION
Ruchira Glaser, EVP & Global Head, CVRM Development, Novartis
Nouhad Husseini, SVP, Head, BD & Corporate Strategy, Regeneron
Marc Tessier-Lavigne, CEO, Xaira
Jingsong Wang, CEO, Harbour BioMed
Moderator: Philippe Lopes-Fernandes, CBO, Ipsen
9:15 am
FIRESIDE CHAT
Robert Plenge, EVP, R&D, BMS
9:35 am
GUBERNATORIAL KEYNOTE
Gavin Newsom, Governor, California
9:55 am
NETWORKING BREAK
10:15 am
CROSSROADS OF SCIENCE & POLICY: SUSTAINING THE ENGINE OF INNOVATION
Robert Califf, former Commissioner, FDA
Moderator: Harvey Berger, CEO, Arena BioWorks
10:45 am
PATIENT-CENTRIC DEVELOPMENT
Mike Exton, CEO, Lexicon Pharmaceuticals
Anne Klibanski, CEO, Mass General Brigham
Richard Wilson, SVP, Primary Focus Lead, Genetic Regulation, Astellas
11:15 am
MANAGING THE RUNWAY
Kabir Nath, CEO, Compass Pathways
11:45 am
PIPELINE PRIORITIZATION
Eliav Barr, CMO & Head, Global Clinical Development, Merck
Marianne De Backer, CEO, Vir Bio
Ruxandra Draghia-Akli, EVP, Head, R&D, Novavax
Lara Sullivan, CEO, Pyxis Oncology
12:15 pm
NETWORKING LUNCHEON
1:00 pm
FIRESIDE CHAT
Teresa Graham, CEO, Roche Pharma
1:20 pm
IDENTIFYING NEXT-GENERATION THERAPEUTICS
Angela Hwang, CEO, Metaphore Therapeutics
Daphne Koller, CEO, Insitro
Phil Vickers, CEO, Solu Therapeutics
Moderator: Zhen Su, CEO, Marengo Therapeutics
1:50 pm
ADVANCING LATE-STAGE ASSETS
Vikram Karnani, CEO, Collegium Pharmaceuticals
2:20 pm
NETWORKING BREAK
2:50 pm
FIRESIDE CHAT
Jay Bradner, EVP, R&D, Amgen
3:10 pm
ENSURING GLOBAL ACCESS
3:40 pm
ASSESSING INVESTMENT RISK
Ansbert Gadicke, Managing Partner, MPM BioImpact
Speaking Faculty
